The project aims to develop a new generation of targeted cancer therapeutics. PIQUR has identified a novel, innovative, dual PI3K/mTOR inhibitor comparing favourably with the most advanced clinical compounds with respect to off-target profile and pharmacological properties. (bron: www.eurekanetwork.org/project-search)
